ÂÜÀòÂÒÂ×

Manfred Schneider is a certified toxicologist and ADME/PK specialist with almost 25 years of broad-based experience in various fields of pharmaceutical R&D. Since 2013, he is a consultant for several large and small pharmaceutical companies with a strong proven track record, in particular, five recent successful small-molecule nonclinical safety packages and the subsequent bioanalytical and PK evaluation of the clinical trials up to Phase II. All projects are still ongoing and the most advanced projects (cancer immunotherapy and neurodegenerative diseases) alone resulted in several successful financing rounds (currently exceeding $100 Mio). He received his Ph.D. in Chemistry from the University of Ulm in Germany and holds a US board certification as a toxicologist (DABT). Following a molecular toxicology postdoc at UC Berkeley, Manfred worked at Tularik, Forest Laboratories, was head of early ADME at Merck Serono, and head of DMPK & TOX at Addex.